Research Pipeline
 
Since the end of 2009, the company a total of nine countries 1.1 class new drug application for registration, six of them have obtained the approval documents of clinical.
 
 

Email | Terms of Use | Contact us

2014版權?軒竹生物科技股份有限公司保留所有權利 冀ICP備2020028968號

99re 这里只有精品,精品视频国产狼友视频,精品人妻少妇一区二区